Jose R. Provenza

Campinas, RS, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Journal: Advances in rheumatology (London, England)

Published: July 21, 2025

Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"

Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"

Journal: Advances in rheumatology (London, England)

Published: July 17, 2025

Review of fibromyalgia treatment guidelines: part 2 - pharmacological treatment.

Review of fibromyalgia treatment guidelines: part 2 - pharmacological treatment.

Journal: Advances in rheumatology (London, England)

Published: March 16, 2025

Brazilian Society of Rheumatology's fibromyalgia treatment guidelines - part I: monitoring and non-pharmacological management.

Brazilian Society of Rheumatology's fibromyalgia treatment guidelines - part I: monitoring and non-pharmacological management.

Journal: Advances in rheumatology (London, England)

Published: March 16, 2025

Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Journal: Advances in rheumatology (London, England)

Published: October 02, 2024

Participating as a research team during the COVID-19 pandemic benefits mental health of undergraduate medical students in Brazil.

Participating as a research team during the COVID-19 pandemic benefits mental health of undergraduate medical students in Brazil.

Journal: Psychology, health & medicine

Published: November 04, 2022

How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study.

How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: June 14, 2022

Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis.

Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis.

Journal: Advances in rheumatology (London, England)

Published: June 25, 2021

Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.

Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.

Journal: Clinical and experimental rheumatology

Published: May 10, 2021

Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.

Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.

Journal: Advances in rheumatology (London, England)

Published: April 02, 2021

Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students' Educational Routines and Mental Health: Protocol for a Web-Based Survey Study.

Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students' Educational Routines and Mental Health: Protocol for a Web-Based Survey Study.

Journal: JMIR research protocols

Published: September 28, 2020

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.

Journal: RMD open

Published: September 27, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026